Petvivo Holdings Inc (PETV) 1.4730 $PETV Veterinary

New Post Public Reply Private Reply Replies (0) Message Board

Jun 4, 2016 at 5:13 AM

Petvivo Holdings Inc (PETV) 1.4730 $PETV

Veterinary Experts Join PetVivo Advisory Board
GlobeNewswire - Thu May 26, 6:00AM CDT
MINNEAPOLIS, MN May 26, 2016 PetVivo Holdings, Inc. (OTCPINK

ETV) an emerging biomedical device company focused on the commercialization of innovative medical devices and therapeutics for pets is very pleased to announce that John Wagoner and Brian Barnett, DVM have joined the PetVivo Veterinary Advisory Board. Mr. Wagoner and Dr. Barnett each bring the company more that twenty years of experience in the veterinary field.

PetVivo to Present at the MicroCap Investor Conference
ACCESSWIRE - Mon May 02, 6:01AM CDT
MINNEAPOLIS, MN / ACCESSWIRE / May 2, 2016 / PetVivo Holdings, Inc. (OTCPINK: PETV) an emerging biomedical device company focused on the commercialization of innovative medical devices and therapeutics for pets is pleased to announce that the company will be presenting at 3rd annual Growth Capital Expo MicroCap Investor Conference, held on May 3rd - 5th, 2016 at Caesars Palace in Las Vegas, NV.

PetVivo Expands IP Assets with EU Drug Delivery Patent Grant
ACCESSWIRE - Mon Oct 26, 3:00PM CDT
MINNEAPOLIS, MN / ACCESSWIRE / October 26, 2015 / PetVivo Holdings, Inc. (OTCPINK: PETV), an emerging biomedical device company focused on the commercialization of innovative medical devices for pets or pet therapeutics, is pleased to announce the issuance of European Patent 1,691,746. With this recent issuance by the European Patent Office, PetVivo's intellectual property portfolio has grown to twenty patents, eight of which are United States Patents. The company has an additional seventeen patent applications pending in the United States and strategic foreign countries.

PetVivo CEO John Lai to Present at the Aegis Growth Conference
ACCESSWIRE - Mon Oct 05, 6:31AM CDT
MINNEAPOLIS, MN / ACCESSWIRE / October 5, 2015 / PetVivo Holdings, Inc. (PINKSHEETS: PETV), an emerging biomedical device company focused on the licensing and commercialization of innovative medical devices & therapeutics for pets, announced today that Mr. John Lai, Chief Executive Officer of PetVivo Holdings, will present at the 2015 Aegis Capital Growth Conference on Friday, October 9, 2015 at the The Encore at Wynn Las Vegas.

PetVivo Continues Expansion of IP Assets With Canadian Patent Grant
ACCESSWIRE - Mon Sep 21, 3:00PM CDT
MINNEAPOLIS, MN / ACCESSWIRE / September 21, 2015 / PetVivo Holdings, Inc. (PINKSHEETS: PETV) an emerging biomedical device company focused on the commercialization of innovative medical devices for pets or pet therapeutics is pleased to announce the grant of Canadian Patent Number 2,583,561 titled "Biocompatible Protein Particles, Particle Devices and Methods Thereof." PetVivo's intellectual property assets have now grown to twenty patents.

PetVivo Holdings to Present at the 2015 Growth Capital Expo
ACCESSWIRE - Thu Apr 09, 6:01AM CDT
MINNEAPOLIS, MN / ACCESSWIRE / April 9, 2015 / PetVivo Holdings, Inc. (PINKSHEETS

ETV) an emerging biomedical device company focused on the licensing and commercialization of innovative medical devices & therapeutics for pets is pleased to announce that the company will be presenting at the 2nd Annual Growth Capital Expo on April 14, 2015 at Caesars Palace in Las Vegas, NV.

PetVivo's Kush Devices Gain Further IP Protection With Patent Allowance
ACCESSWIRE - Wed Mar 25, 6:02AM CDT
MINNEAPOLIS, MN / ACCESSWIRE / March 25, 2015 / PetVivo Holdings, Inc. (PINKSHEETS

ETV) an emerging biomedical device company focused on the licensing and commercialization of innovative medical devices for pets or pet therapeutics is pleased to announce an additional patent allowance for its merging partner Gel-Del Technologies, Inc. This Canadian Patent allowance secures intellectual property related to PetVivo's Kush device for the treatment of osteoarthritis and other particle devices. PetVivo Holdings and Gel-Del Technologies previously announced that they entered into a definitive stock exchange agreement that is scheduled to close by March 31, 2015.

PetVivo's Merger Partner Strengthens Canadian IP Portfolio with Stent Patent Allowance
ACCESSWIRE - Mon Mar 09, 6:01AM CDT
MINNEAPOLIS, MN / ACCESSWIRE / March 9, 2015 / PetVivo Holdings, Inc. (PINKSHEETS

ETV) an emerging biomedical device company focused on the licensing and commercialization of innovative medical devices and therapeutics for pets is pleased to announce that the patent portfolio of its merging partner Gel-Del Technologies, Inc. has grown to eighteen allowed patents, with an additional eighteen patent applications pending in the US and strategic foreign countries. PetVivo Holdings and Gel-Del Technologies previously announced that they entered into a definitive stock exchange agreement that is scheduled to close by March 31, 2015.

PetVivo Announces the Continued Expansion of Gel-Del's Intellectual Property Portfolio
ACCESSWIRE - Mon Jan 12, 6:02AM CST
Untitled Document

PetVivo Announces Definitive Merger Agreement with Gel-Del Technologies
ACCESSWIRE - Mon Nov 24, 6:00AM CST
MINNEAPOLIS, MN / ACCESSWIRE / November 24, 2014 / PetVivo Holdings, Inc. (OTCPINK

ETV) an emerging biomedical device company focused on the licensing and commercialization of innovative medical devices for pets, or pet therapeutics is pleased to announce that they have entered into a definitive stock exchange agreement with Gel-Del Technologies, Inc.

Small Cap Traders Offers Brief Report: When Going to the Dogs Is a Good Thing
PR Newswire - Wed Nov 05, 6:00AM CST
Analyst Report by Small Cap Traders. PetVivo, Inc. is a wholly owned subsidiary of PetVivo Holdings, Inc. (OTCBB: PETV). PetVivo is an emerging biomedical device company focused on the licensing and commercialization of innovative medical devices and other therapeutics for pets.

PetVivo Announces Interview with CEO John Lai on MCN Channel 6
ACCESSWIRE - Fri Oct 31, 6:00AM CDT
Minneapolis, MN / ACCESSWIRE / October 31, 2014 / PetVivo Holdings, Inc. (OTCPINK: PETV) an emerging biomedical device company focused on the licensing and commercialization of innovative medical devices and pet therapeutics is pleased to announce that CEO John Lai was recently interviewed by Metro Cable Network - Channel 6 host Mike Woodley regarding PetVivo's recent progress and future plans.

Petvivo CEO John Lai to Present at The 2015 Marcum Microcap Conference
ACCESSWIRE - Wed May 14, 6:01AM CDT
MINNEAPOLIS, MN / ACCESSWIRE / May 14, 2015 / PetVivo Holdings, Inc. (OTCPINK: PETV), an emerging biomedical device company focused on the licensing and commercialization of innovative medical devices & therapeutics for pets, announced today that Mr. John Lai, Chief Executive Officer of PetVivo Holdings, will present at the 2015 Marcum MicroCap Conference on Thursday, May 28, 2015 in New York City at the Grand Hyatt Hotel.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

DIRECTV Bags New NHL Deals: Stakes for Sports Fans

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Likang's Bold Move: Cancer Immunotherapy at AD Summit

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

DigitalXForce Booms with 514% Growth and Major Backing

Massive Growth and Strategic Investment in DigitalXForce Now here’s a company that’s shaking things up—DigitalXForce. Right on the back of a staggering 514% growth, they’ve corralled a strategic investment from Arsenal Growth Equity. If you blink, you might miss just how fast they’re sprinting through the tech landscape. Institutional Support Backing the...

CapCut's AI Tools Reshape Video Content Creation

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

World Young Scientist Summit 2026 in Wenzhou Kicks Off

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Spooky Dining at CARNE: A Halloween Hit in Oxnard

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Alaska's Insurance Maze: Coverage Over Cheap Policies

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...